$0.3555
0.005551.59%
Last update: Nov 4, 12:03 PM
Actuate Therapeutics Inc
ACTUNASDAQ
The average analyst price target for Actuate Therapeutics is $13.67, 3744.7% above the current price. Of 3 analysts, 3 rate it Buy. Targets range from $6 to $20. The latest change came on Jul 30, 2026, when Rodman & Renshaw initiated coverage of Actuate Therapeutics with a Buy rating and a $6 price target.
Price Target Range — 5 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months
